Open AccessHeparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19
Author(s) -
Jingyu Xiang,
Mijia Lu,
Min Shi,
Xiaogang Cheng,
Kristin A. Kwakwa,
Jennifer L. Davis,
Xinming Su,
Suzanne J. Bakewell,
Yuexiu Zhang,
Francesca Fontana,
Yalin Xu,
Deborah J. Veis,
John F. DiPersio,
Lee Ratner,
Ralph D. Sanderson,
Alessandro Noseda,
Shamim Mollah,
Jiànróng Lǐ,
Katherine N. Weilbaecher
Publication year - 2022
Publication title -
journal of virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.617
H-Index - 292
eISSN - 1070-6321
pISSN - 0022-538X
DOI - 10.1128/jvi.00057-22
Subject(s) - biology , blockade , covid-19 , pathogenesis , inflammation , immunology , coronavirus , virology , viral replication , virus , disease , medicine , receptor , pathology , genetics , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom